Log In / Sign Up

SB 783

  • Wisconsin Senate Bill
  • 2023-2024 Regular Session
  • Introduced in Senate Dec 08, 2023
  • Senate
  • Assembly
  • Governor

Relating to: therapeutic interchange for drug products prescribed to counteract anaphylaxis.

View Latest Bill Text
Sign In to Follow

Abstract

Bill Sponsors (4)

Mark Spreitzer

  • Democratic
  • Senator
  • District 15
Primary

Jeff Smith

  • Democratic
  • Senator
  • District 31
Primary

Lena Taylor

  • Democratic
Primary

Bob Wirch

  • Democratic
  • Senator
  • District 22
Primary

Votes

No votes to display

Actions

Apr 15, 2024

Senate

Failed to pass pursuant to Senate Joint Resolution 1

Jan 25, 2024

Senate

Representative Haywood added as a cosponsor

Jan 18, 2024

Senate

Public hearing held

Dec 22, 2023

Senate

Representative Subeck added as a cosponsor

Dec 14, 2023

Senate

Senator Agard added as a coauthor

Dec 08, 2023

Senate

Introduced by Senators Spreitzer, Smith, Taylor and Wirch; cosponsored by Representatives Vining, C. Anderson, J. Anderson, Clancy, Conley, Considine, Drake, Emerson, Joers, Madison, Ohnstad, Ortiz-Velez, Ratcliff, Shankland and Sinicki

Senate

Read first time and referred to Committee on Health

Bill Text

Bill Text Versions Format
Bill Text PDF HTML

Related Documents

Document Format
2023 Assembly Bill 849 HTML
Wisconsin Ethics Commission information HTML
LC Bill Hearing Materials HTML
SB783 ROCP for Committee on Health HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Wisconsin State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.